Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

<p>Prognostic value of aspartate transaminase to alanine transaminase (De Ritis) ratio in solid tumors: a pooled analysis of 9,400 patients</p>
Jiayuan Wu, Lin Chen, Yufeng Wang, et al.
OncoTargets and Therapy (2019) Vol. Volume 12, pp. 5201-5213
Open Access | Times Cited: 48

Showing 1-25 of 48 citing articles:

Machine Learning in Prediction of Bladder Cancer on Clinical Laboratory Data
I-Jung Tsai, Wen‐Chi Shen, Chien‐Chung Lin, et al.
Diagnostics (2022) Vol. 12, Iss. 1, pp. 203-203
Open Access | Times Cited: 32
The prognostic role of the AST/ALT ratio in hepatocellular carcinoma patients receiving thermal ablation combined with simultaneous TACE
Feihang Wang, Shanshan Gao, Mengfei Wu, et al.
BMC Gastroenterology (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 13
Prognostic Value of Aspartate Transaminase/Alanine Transaminase Ratio in Patients With Hepatitis B Virus-Related Hepatocellular Carcinoma Undergoing Hepatectomy
Qiuyan Mo, Yingchun Liu, Zihan Zhou, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 15
Carotenoid isolates ofSpondias mombindemonstrate anticancer effects in DMBA‐induced breast cancer in Wistar rats through X‐linked inhibitor of apoptosis protein (XIAP) antagonism and anti‐inflammation
Damilohun Samuel Metibemu, Oluseyi Adeboye Akinloye, Adio Jamiu Akamo, et al.
Journal of Food Biochemistry (2020) Vol. 44, Iss. 12
Open Access | Times Cited: 22
The Prognostic Value of the De Ritis Ratio for Progression-Free Survival in Patients with NET Undergoing [177Lu]Lu-DOTATOC-PRRT: A Retrospective Analysis
Tristan Ruhwedel, Julian M.M. Rogasch, Kai Huang, et al.
Cancers (2021) Vol. 13, Iss. 4, pp. 635-635
Open Access | Times Cited: 15
Novel Postoperative Serum Biomarkers in Atypical Meningiomas: A Multicenter Study
Won Ick Chang, Hwa Kyung Byun, Joo Ho Lee, et al.
Neurosurgery (2023) Vol. 93, Iss. 3, pp. 599-610
Closed Access | Times Cited: 6
Breast cancer cell growth arrest and chemopreventive effects of Passiflora edulis Sims (Passifloraceae) ethanolic leaves extract on a rat model of mammary carcinoma
Sorelle Ines Fotsing, Judith Christiane Ngo Pambe, Kevine Kamga Silihe, et al.
Journal of Ethnopharmacology (2023) Vol. 311, pp. 116408-116408
Closed Access | Times Cited: 6
Association of De Ritis ratio with oncological outcomes in patients with non-muscle invasive bladder cancer (NMIBC)
Ekaterina Laukhtina, Hadi Mostafaei, David D’Andrea, et al.
World Journal of Urology (2020) Vol. 39, Iss. 6, pp. 1961-1968
Open Access | Times Cited: 16
Prognostic Role of Pretreatment De Ritis Ratio (Aspartate Transaminase/Alanine Transaminase Ratio) in Urological Cancers: A Systematic Review and Meta-Analysis
Shiqiang Su, Lizhe Liu, Chao Li, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 16
Prognostic Value of the De Ritis Ratio for Overall Survival in Patients with Metastatic Castration-Resistant Prostate Cancer Undergoing [177Lu]Lu-PSMA-617 Radioligand Therapy
Sebastian Gaal, Kai Huang, Julian M.M. Rogasch, et al.
Cancers (2023) Vol. 15, Iss. 20, pp. 4907-4907
Open Access | Times Cited: 5
<p>Pretreatment Aspartate Aminotransferase-to-Alanine Aminotransferase (De Ritis) Ratio Predicts the Prognosis of Nonmetastatic Nasopharyngeal Carcinoma</p>
Jiayuan Wu, Shasha Li, Yufeng Wang, et al.
OncoTargets and Therapy (2019) Vol. Volume 12, pp. 10077-10087
Open Access | Times Cited: 11
The Prognosis Role of AST/ALT (De Ritis) Ratio in Patients with Adult Secondary Hemophagocytic Lymphohistiocytosis
Guangli Yin, Changfeng Man, Shengen Liao, et al.
Mediators of Inflammation (2020) Vol. 2020, pp. 1-10
Open Access | Times Cited: 11
Model for End-Stage Liver Disease Correlates with Disease Relapse and Death of Patients with Merkel Cell Carcinoma
Thilo Gambichler, Jürgen C. Becker, Laura Susok, et al.
Cancers (2023) Vol. 15, Iss. 12, pp. 3195-3195
Open Access | Times Cited: 4
Prognostic Effect of the PNI and LSR in Patients with Esophageal Squamous Cell Carcinoma Patients Receiving Radiotherapy
Junfeng Gao, Meimei Li, Yi Wang, et al.
Journal of Gastrointestinal Cancer (2024) Vol. 56, Iss. 1
Closed Access | Times Cited: 1
The aspartate aminotransaminase/alanine aminotransaminase (De Ritis) ratio predicts sensitivity to radiotherapy in head and neck carcinoma patients
Aina Sansa, María del Prado Venegas, Cristina Valero, et al.
Head & Neck (2021) Vol. 43, Iss. 7, pp. 2091-2100
Closed Access | Times Cited: 9
Elevated De Ritis Ratio as a Predictor for Acute Kidney Injury after Radical Retropubic Prostatectomy
Jun-Young Park, Jihion Yu, Jun Hyuk Hong, et al.
Journal of Personalized Medicine (2021) Vol. 11, Iss. 9, pp. 836-836
Open Access | Times Cited: 9
Predictive value of De Ritis ratio in metastatic renal cell carcinoma treated with tyrosine-kinase inhibitors
Florian Janisch, Thomas Klotzbücher, Phillip Marks, et al.
World Journal of Urology (2021) Vol. 39, Iss. 8, pp. 2977-2985
Open Access | Times Cited: 8
Factors associated with pathological tumor stage and T3a upstage in clinical T1-2 renal cell carcinoma
Nadir Kalfazade, Deniz Noyan Özlü, Emre Şam, et al.
Progrès en Urologie (2023) Vol. 33, Iss. 3, pp. 135-144
Closed Access | Times Cited: 3
Plasma Markers for Therapy Response Monitoring in Patients with Neuroendocrine Tumors Undergoing Peptide Receptor Radionuclide Therapy
Christoph Wetz, Tristan Ruhwedel, Imke Schatka, et al.
Cancers (2023) Vol. 15, Iss. 24, pp. 5717-5717
Open Access | Times Cited: 3
The significance of De Ritis ratio in patients with radiation-recurrent prostate cancer undergoing salvage radical prostatectomy
Fahad Quhal, Mohammad Abufaraj, Florian Janisch, et al.
Arab Journal of Urology (2020) Vol. 18, Iss. 4, pp. 213-218
Open Access | Times Cited: 8
Comparison of De Ritis Ratio and other systemic inflammatory parameters for the prediction of prognosis of patients with transitional cell bladder cancer
Ali Furkan Batur, Muhammed Furkan Furkan Aydoğan, Özcan Kılıç, et al.
International Journal of Clinical Practice (2020) Vol. 75, Iss. 4
Closed Access | Times Cited: 7
Anti-PADI4 antibody suppresses breast cancer by repressing the citrullinated fibronectin in the tumor microenvironment
Yan Wang, Chunyan Liu, Nanyang Zhang, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 153, pp. 113289-113289
Closed Access | Times Cited: 5
A retrospective cross-sectional study for predicting 72-h mortality in patients with serum aspartate aminotransferase levels ≥ 3000 U/L
Kai Saito, Hitoshi Sugawara, Tamami Watanabe, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 6
Development of a Prognostic Score for Cholangiocarcinoma Patients Using a Combination of Biochemical Parameters
HTET HTET MIN-OO, TIN MAY AUNG, Molin Wongwattanakul, et al.
In Vivo (2023) Vol. 37, Iss. 3, pp. 1145-1155
Open Access | Times Cited: 2
Association of preoperative serum De Ritis ratio with oncological outcomes in patients treated with cytoreductive nephrectomy for metastatic renal cell carcinoma
Ekaterina Laukhtina, Benjamin Pradère, David D’Andrea, et al.
Urologic Oncology Seminars and Original Investigations (2020) Vol. 38, Iss. 12, pp. 936.e7-936.e14
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top